SCH-900271

TargetMol
Product Code: TAR-T34573
Supplier: TargetMol
CodeSizePrice
TAR-T34573-1mg1mg£167.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-1mL1 mL * 10 mM (in DMSO)£292.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-5mg5mg£303.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-10mg10mg£424.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-25mg25mg£655.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-50mg50mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-100mg100mg£1,187.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T34573-500mg500mg£2,295.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Sch-900271 is an effective nicotinic acid receptor for the treatment of dyslipidemia.
CAS:
915210-50-3
Formula:
C14H16N2O4
Molecular Weight:
276.292
Pathway:
Neuroscience
Purity:
0.98
SMILES:
CC1(CCCc2cc(=O)oc3[nH]c(=O)[nH]c(=O)c23)CC1
Target:
AChR

References

Palani A, et al. Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia. ACS Med Chem Lett. 2011 ; 3(1):63-68. Lauring B, et al. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Sci Transl Med. 2012 ; 4(148): 115.